Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.34%721.85M | -13.06%503.82M | -24.88%256.69M | -38.11%1.04B | -41.48%814.17M | -38.28%579.49M | -35.69%341.69M | 0.63%1.69B | 7.43%1.39B | 16.01%938.87M |
| Operating revenue | -11.34%721.85M | -13.06%503.82M | -24.88%256.69M | -38.11%1.04B | -41.48%814.17M | -38.28%579.49M | -35.69%341.69M | 0.63%1.69B | 7.43%1.39B | 16.01%938.87M |
| Other operating revenue | ---- | 438.94%45.31M | ---- | 294.69%42.9M | ---- | -28.54%8.41M | ---- | -27.24%10.87M | ---- | 23.34%11.76M |
| Total operating cost | -11.07%804.07M | -8.89%556.44M | -17.86%284.84M | -36.99%1.19B | -41.20%904.12M | -41.62%610.73M | -41.14%346.76M | 12.23%1.89B | 22.72%1.54B | 38.12%1.05B |
| Operating cost | -9.95%636.64M | -7.07%443.13M | -17.97%228.05M | -41.98%934.75M | -46.65%707M | -47.44%476.84M | -46.43%278.01M | 11.12%1.61B | 21.36%1.33B | 39.09%907.31M |
| Operating tax surcharges | 12.56%2.9M | -7.62%1.64M | -0.94%1.06M | 17.46%5.53M | 5.86%2.58M | 5.84%1.78M | 40.18%1.07M | 10.07%4.71M | 241.70%2.43M | 19.91%1.68M |
| Operating expense | -12.80%88.39M | -13.38%58.24M | -7.44%31.53M | -0.57%131M | -1.74%101.36M | -1.94%67.23M | -0.25%34.07M | 13.74%131.75M | 21.46%103.15M | 21.32%68.56M |
| Administration expense | -16.28%43.63M | -11.98%31.31M | -29.65%14.71M | -7.60%64.87M | 2.97%52.11M | 6.77%35.57M | 27.26%20.91M | 21.20%70.2M | 14.52%50.61M | 11.64%33.31M |
| Financial expense | -8.88%22.24M | -14.11%15.03M | -18.36%7.1M | -16.88%32.43M | -14.93%24.41M | -0.75%17.49M | -7.05%8.7M | 101.25%39.02M | 181.83%28.69M | 182.31%17.63M |
| -Interest expense (Financial expense) | -23.14%18.75M | -21.45%12.87M | -20.94%6.41M | -12.42%32.22M | -10.73%24.4M | -5.81%16.39M | 6.84%8.11M | 83.94%36.79M | 134.45%27.34M | 120.88%17.4M |
| -Interest Income (Financial expense) | 76.81%-575.95K | -15.22%-471.88K | -13.41%-257.86K | -72.29%-2.67M | -112.53%-2.48M | 48.58%-409.55K | 30.45%-227.36K | 30.90%-1.55M | 35.20%-1.17M | 38.17%-796.45K |
| Research and development | -38.35%10.27M | -39.87%7.1M | -40.43%2.38M | -32.64%21.58M | -39.69%16.66M | -33.35%11.81M | -57.91%3.99M | -10.30%32.04M | 30.85%27.62M | 58.32%17.72M |
| Credit Impairment Loss | -866.80%-2.68M | -107.95%-102.79K | -193.27%-338.46K | 51.23%-4.18M | -153.72%-276.74K | 11.58%1.29M | -74.23%362.87K | -17,252.19%-8.58M | -101.64%-109.07K | -63.86%1.16M |
| Asset Impairment Loss | -59.32%-32.99M | -281.68%-23.5M | 9.34%-7.17M | -62.98%-62.43M | -39.49%-20.7M | -15.79%-6.16M | -981.90%-7.91M | -119.94%-38.31M | -113.92%-14.84M | -7,947.05%-5.32M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Other net revenue | 232.74%22.52M | -2,321.72%-26.58M | 19.02%-6.13M | 35.36%-31.87M | -4.68%-16.96M | 79.23%-1.1M | -2,633.32%-7.57M | -66.41%-49.31M | -58.77%-16.21M | -82.39%-5.28M |
| Fair value change income | -2,475.00%-3.7M | -1,013.12%-3.39M | --1.26M | ---424.4K | -371.56%-143.56K | -136.95%-304.73K | ---- | ---- | 99.11%-30.44K | 95.46%-128.6K |
| Invest income | 25,728.36%60.94M | 145.38%84.49K | 70.48%-88.52K | 99.69%-12.24K | 92.47%-237.78K | 93.58%-186.17K | 86.08%-299.89K | 72.27%-4.01M | 62.49%-3.16M | 22.00%-2.9M |
| -Including: Investment income associates | 84.70%282.25K | 15.37%356.34K | ---- | 783.77%612.2K | -55.46%152.82K | 7.95%308.87K | 36.94%-77.87K | -354.19%-89.53K | 443.11%343.13K | 187.45%286.13K |
| Asset deal income | -133.75%-79.91K | -204.86%-230.01K | -113.72%-26.25K | 2,674.50%34.34M | -85.88%236.78K | -87.37%219.34K | -88.82%191.36K | -17.43%1.24M | 16.57%1.68M | 545.78%1.74M |
| Other revenue | -75.51%1.02M | -86.33%551.66K | 168.97%232.41K | 136.10%839.97K | 1,506.76%4.16M | 2,340.85%4.04M | -0.44%86.41K | -56.34%355.77K | -48.08%259.07K | -31.96%165.37K |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%0.01 |
| Operating profit | 44.16%-59.7M | -144.93%-79.2M | -171.43%-34.28M | 29.11%-177.42M | 34.24%-106.91M | 71.29%-32.34M | 78.05%-12.63M | -608.75%-250.26M | -609.86%-162.57M | -330.30%-112.63M |
| Add:Non operating Income | 116.15%74.9K | 4,732.35%73.58K | ---- | 8.40%765.52K | -82.82%34.65K | -96.66%1.52K | -89.87%1.52K | 163.58%706.22K | 4.54%201.71K | -39.80%45.64K |
| Less:Non operating expense | -78.92%357.77K | -79.25%301.4K | -79.89%259.84K | 305.00%4.23M | 103.72%1.7M | 116.57%1.45M | 323.39%1.29M | -75.02%1.04M | -74.00%833.08K | -77.62%670.73K |
| Total profit | 44.76%-59.98M | -135.08%-79.43M | -148.13%-34.54M | 27.82%-180.88M | 33.47%-108.57M | 70.16%-33.79M | 75.93%-13.92M | -538.92%-250.6M | -665.23%-163.2M | -346.29%-113.25M |
| Less:Income tax cost | 141.36%9.51M | -5.64%-5.05M | -17,817.00%-6.74M | 123.52%13.06M | 44.63%-23.01M | 83.43%-4.78M | 99.76%-37.62K | -984.73%-55.53M | -565.31%-41.55M | -300.81%-28.88M |
| Net profit | 18.78%-69.49M | -156.43%-74.38M | -100.24%-27.8M | 0.58%-193.94M | 29.67%-85.57M | 65.62%-29M | 67.19%-13.88M | -471.99%-195.07M | -709.96%-121.66M | -366.99%-84.37M |
| Net profit from continuing operation | 18.78%-69.49M | -156.43%-74.38M | -100.24%-27.8M | 0.58%-193.94M | 29.67%-85.57M | 65.62%-29M | 67.19%-13.88M | -471.99%-195.07M | -709.96%-121.66M | -366.99%-84.37M |
| Less:Minority Profit | -89.42%-30.85M | -1,000.08%-16.58M | -196.92%-5.18M | -6.14%-49.13M | 48.97%-16.29M | 93.87%-1.51M | 86.96%-1.74M | -1,167.50%-46.28M | -299.73%-31.92M | -217.96%-24.57M |
| Net profit of parent company owners | 44.22%-38.64M | -110.20%-57.8M | -86.36%-22.62M | 2.67%-144.82M | 22.80%-69.28M | 54.02%-27.5M | 58.07%-12.14M | -287.07%-148.78M | -2,363.67%-89.74M | -655.08%-59.8M |
| Earning per share | ||||||||||
| Basic earning per share | 43.75%-0.09 | -116.67%-0.13 | -66.67%-0.05 | 2.86%-0.34 | 23.81%-0.16 | 57.14%-0.06 | 57.14%-0.03 | -288.89%-0.35 | -2,200.00%-0.21 | -566.67%-0.14 |
| Diluted earning per share | 43.75%-0.09 | -116.67%-0.13 | -66.67%-0.05 | 2.86%-0.34 | 23.81%-0.16 | 57.14%-0.06 | 57.14%-0.03 | -288.89%-0.35 | -2,200.00%-0.21 | -566.67%-0.14 |
| Other composite income | 43.96%-1.39M | -144.69%-275.61K | -88.58%28.16K | -60.29%1.77M | -135.08%-2.48M | -93.05%616.66K | 108.98%246.47K | -78.24%4.47M | -73.10%7.08M | -28.40%8.87M |
| Other composite income of parent company owners | 43.96%-1.39M | -144.69%-275.61K | -88.58%28.16K | -60.29%1.77M | -135.08%-2.48M | -93.05%616.66K | 108.98%246.47K | -78.24%4.47M | -73.10%7.08M | -28.40%8.87M |
| Total composite income | 19.49%-70.89M | -162.97%-74.65M | -103.66%-27.77M | -0.82%-192.17M | 23.16%-88.05M | 62.40%-28.39M | 69.74%-13.64M | -1,305.16%-190.6M | -347.72%-114.58M | -271.65%-75.51M |
| Total composite income of parent company owners | 44.21%-40.03M | -116.04%-58.07M | -89.89%-22.59M | 0.88%-143.04M | 13.19%-71.76M | 47.23%-26.88M | 62.46%-11.9M | -706.23%-144.32M | -373.04%-82.66M | -319.93%-50.94M |
| Total composite income of minority owners | -89.42%-30.85M | -1,000.08%-16.58M | -197.92%-5.18M | -6.14%-49.13M | 48.97%-16.29M | 93.87%-1.51M | 87.00%-1.74M | -1,167.50%-46.28M | -299.73%-31.92M | -217.96%-24.57M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.